Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with disorders affecting the peripheral and the central nervous system. A high number of patients develop post-COVID-19 syndrome with the persistence of a large spectrum of symptoms, including neurological,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonetto, Valentina, Pasetto, Laura, Lisi, Ilaria, Carbonara, Marco, Zangari, Rosalia, Ferrari, Erica, Punzi, Veronica, Luotti, Silvia, Bottino, Nicola, Biagianti, Bruno, Moglia, Cristina, Fuda, Giuseppe, Gualtierotti, Roberta, Blasi, Francesco, Canetta, Ciro, Montano, Nicola, Tettamanti, Mauro, Camera, Giorgia, Grimoldi, Maria, Negro, Giulia, Rifino, Nicola, Calvo, Andrea, Brambilla, Paolo, Biroli, Francesco, Bandera, Alessandra, Nobili, Alessandro, Stocchetti, Nino, Sessa, Maria, Zanier, Elisa R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798841/
https://www.ncbi.nlm.nih.gov/pubmed/36591311
http://dx.doi.org/10.3389/fimmu.2022.1070379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798841/
https://www.ncbi.nlm.nih.gov/pubmed/36591311
http://dx.doi.org/10.3389/fimmu.2022.1070379

Ejemplares similares